🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Sagility Limited SAGILITY NIFTY_SMALLNSEPHARMA

Healthcare · Health Information Services · India
https://www.sagilityhealth.com

Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrative support provider, and data management services. It also provides utilization and care management, and population health management, as well as revenue cycle management functions, such as financial clearance, medical coding, billing, labs and durable medical equipment support, patient access and engagement, and accounts receivable follow-up services. In addition, it provides services to pharmacy benefit managers that manage prescription drugs for members under health insurance plans. Further, it offers various platforms, including document processing engine, genAI solutions for customer and member engagement, nurse assist, revenue cycle management, provider forward, enrolment and plan automation, and contract central. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. The company was incorporated in 2021 and is based in Bengaluru, India. Sagility Limited operates as a subsidiary of Sagility B.V.

READ MORE ›
₹41.04
+4.40% 1Y

Market & Price

Market Cap
₹19,212.17 Cr
Current Price
₹41.04
High / Low (52W)
₹54.53 / ₹36.35
Beta
-

Valuation

Stock P/E
20.73
Industry PE
37.60
Forward P/E
14.20
PEG Ratio
-
Book Value
₹18.79
Price to Book
2.18
P/S
2.85
EV/EBITDA
17.39
Dividend Yield
0.23%

Profitability & Returns

ROCE
12.50%
ROE
-
ROA
-
Profit Margin
12.61%
Op Margin
19.66%
EPS (Latest Qtr)
₹0.56
EPS (TTM)
₹1.98

Balance Sheet & Liquidity

Debt/Equity
0.14
Quick Ratio
-
Current Ratio
-
Debt
₹1,231.95 Cr
Total Assets
₹12,601.08 Cr
Current Assets
₹2,944.54 Cr
Working Capital
₹1,047.04 Cr

Ownership

Promoter Holding
50.95%
Chg in Prom Hold
-
FII / Inst Holding
22.64%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹20,866.64 Cr
Total Revenue (TTM)
₹6,737.07 Cr
EBITDA
₹1,200.29 Cr
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
₹468.13 Cr
Gross Margin
36.37%
Payout Ratio
2.53%

Growth (CAGR)

Revenue 5Y
19.47%
Profit 5Y
86.06%
Revenue (YoY)
35.70%
Earnings (YoY)
23.90%

PROS

  • Compounding revenue at 19.5% over 5 years.
  • Profit CAGR of 86.1% over 5 years.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 SAGILITY Sagility Limited NIFTY_SMALLNSEPHARMA 41.04 20.73 ₹19,212.17 Cr 0.23% 12.50% - 19.47% 86.06%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue 1,453.07 Cr1,568.48 Cr1,538.94 Cr1,971.15 Cr2,024.26 Cr
Cost of Revenue 862.00 Cr974.10 Cr987.21 Cr1,219.16 Cr1,276.89 Cr
Gross Profit 591.07 Cr594.38 Cr551.73 Cr752.00 Cr747.37 Cr
Operating Expenses 315.01 Cr335.69 Cr323.83 Cr364.40 Cr386.86 Cr
Operating Income 276.05 Cr258.69 Cr227.90 Cr387.59 Cr360.50 Cr
EBITDA 436.18 Cr383.16 Cr355.98 Cr486.70 Cr509.44 Cr
Interest Expense 30.19 Cr29.83 Cr27.41 Cr24.66 Cr22.10 Cr
Pretax Income 289.81 Cr238.99 Cr210.39 Cr338.52 Cr363.18 Cr
Tax Provision 72.90 Cr56.41 Cr61.83 Cr70.86 Cr105.46 Cr
Net Income 216.91 Cr182.57 Cr148.56 Cr267.66 Cr257.73 Cr
Diluted EPS 0.460.390.320.570.56

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 4,218.41 Cr4,753.56 Cr5,569.92 Cr7,192.85 Cr
Cost of Revenue 2,503.01 Cr2,747.00 Cr3,498.90 Cr4,510.28 Cr
Gross Profit 1,715.40 Cr2,006.55 Cr2,071.02 Cr2,682.57 Cr
Operating Expenses 1,320.35 Cr1,607.67 Cr1,239.99 Cr1,409.67 Cr
Operating Income 395.05 Cr398.88 Cr831.03 Cr1,272.90 Cr
EBITDA 1,044.86 Cr1,116.04 Cr1,354.19 Cr1,825.43 Cr
Interest Expense 214.85 Cr185.15 Cr127.10 Cr99.16 Cr
Pretax Income 185.68 Cr241.68 Cr760.23 Cr1,238.90 Cr
Tax Provision 42.10 Cr13.41 Cr221.11 Cr314.13 Cr
Net Income 143.57 Cr228.27 Cr539.12 Cr924.77 Cr
Diluted EPS 0.310.491.17-

Compounded Sales Growth

5 Years:19.47%
1 Year:35.70%

Compounded Profit Growth

5 Years:86.06%
1 Year:23.90%

Stock Price Performance

1 Year:+4.40%
6 Months:-17.94%
3 Months:-3.21%
1 Month:-1.68%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -10,590.48 Cr10,664.20 Cr11,050.66 Cr12,601.08 Cr
Current Assets -1,793.42 Cr1,719.92 Cr1,820.77 Cr2,944.54 Cr
Cash & Equivalents -585.29 Cr344.13 Cr343.76 Cr357.92 Cr
Inventory -----
Receivables -637.64 Cr742.16 Cr865.82 Cr1,839.03 Cr
Total Liabilities -4,383.81 Cr4,221.07 Cr2,714.61 Cr2,941.98 Cr
Current Liabilities -1,056.44 Cr1,452.12 Cr1,089.10 Cr1,897.50 Cr
Long Term Debt -2,323.70 Cr1,664.70 Cr567.04 Cr0
Total Debt -2,871.60 Cr2,531.71 Cr1,401.94 Cr1,110.54 Cr
Total Equity -6,206.67 Cr6,443.13 Cr8,336.05 Cr9,659.10 Cr
Shares Outstanding -468.13 Cr468.13 Cr468.13 Cr468.13 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 856.78 Cr973.25 Cr1,214.07 Cr1,202.97 Cr
Investing Cash Flow -129.06 Cr-469.06 Cr-964.21 Cr-710.69 Cr
Financing Cash Flow -544.62 Cr-751.34 Cr-256.07 Cr-501.40 Cr
Capital Expenditure -143.68 Cr-182.73 Cr-124.44 Cr-192.21 Cr
Free Cash Flow 713.10 Cr790.53 Cr1,089.63 Cr1,010.76 Cr
Net Change in Cash 183.10 Cr-247.14 Cr-6.21 Cr-9.12 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % 40.7%42.2%37.2%37.3%
Operating Margin % 9.4%8.4%14.9%17.7%
Net Margin % 3.4%4.8%9.7%12.9%
ROE % 2.3%3.5%6.5%9.6%
ROCE % 4.1%4.3%8.3%11.9%

Shareholding Pattern

Insiders
50.95%
Institutions
22.64%
Public Float
46.15%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SAGILITY

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks